SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Adaptimmune Therapeutics PLC – ‘8-K’ for 1/13/20 – ‘XML’

On:  Monday, 1/13/20, at 8:42am ET   ·   For:  1/13/20   ·   Accession #:  1104659-20-3256   ·   File #:  1-37368

Previous ‘8-K’:  ‘8-K’ on / for 1/13/20   ·   Next:  ‘8-K’ on 1/14/20 for 1/13/20   ·   Latest:  ‘8-K’ on 4/12/24 for 4/10/24   ·   7 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/13/20  Adaptimmune Therapeutics PLC      8-K:5,8,9   1/13/20   13:396K                                   Toppan Merrill/FA

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     36K 
 2: EX-10.1     Material Contract                                   HTML     83K 
 3: EX-10.2     Material Contract                                   HTML     42K 
 4: EX-99.1     Miscellaneous Exhibit                               HTML     15K 
 9: R1          Cover                                               HTML     49K 
 8: XML         IDEA XML File -- Filing Summary                      XML     12K 
10: XML         XBRL Instance -- tm201697d1_8k_htm                   XML     15K 
13: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 6: EX-101.LAB  XBRL Labels -- adap-20200113_lab                     XML     97K 
 7: EX-101.PRE  XBRL Presentations -- adap-20200113_pre              XML     64K 
 5: EX-101.SCH  XBRL Schema -- adap-20200113                         XSD     13K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    34K 
12: ZIP         XBRL Zipped Folder -- 0001104659-20-003256-xbrl      Zip     41K 


‘XML’   —   IDEA XML File — Filing Summary


This Document is an IDEA XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.19.3.a.u2 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 1 </ContextCount>
<ElementCount> 97 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> false </FootnotesReported>
<SegmentCount> 0 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 3 </UnitCount>
<MyReports>
<Report instance="tm201697d1_8k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 00000001 - Document - Cover </LongName>
<ReportType> Sheet </ReportType>
<Role> http://adaptimmune.com/role/Cover </Role>
<ShortName> Cover </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<InputFiles>
<File doctype="8-K" original="tm201697d1_8k.htm"> tm201697d1_8k.htm </File>
<File> adap-20200113.xsd </File>
<File> adap-20200113_lab.xml </File>
<File> adap-20200113_pre.xml </File>
<File> tm201697d1_ex10-1.htm </File>
<File> tm201697d1_ex10-2.htm </File>
<File> tm201697d1_ex99-1.htm </File>
</InputFiles>
<SupplementalFiles/>
<BaseTaxonomies>
<BaseTaxonomy> http://xbrl.sec.gov/dei/2019-01-31 </BaseTaxonomy>
</BaseTaxonomies>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> false </HasCalculationLinkbase>
</FilingSummary>


7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/06/24  Adaptimmune Therapeutics plc      10-K       12/31/23  131:16M                                    Toppan Merrill Bridge/FA
 4/18/23  Adaptimmune Therapeutics plc      S-4/A                  7:5.6M                                   Toppan Merrill/FA
 4/05/23  Adaptimmune Therapeutics plc      S-4                    7:4.5M                                   Toppan Merrill/FA
 3/06/23  Adaptimmune Therapeutics plc      10-K       12/31/22  117:15M                                    Toppan Merrill Bridge/FA
 3/14/22  Adaptimmune Therapeutics plc      10-K       12/31/21  109:13M                                    Toppan Merrill Bridge/FA
 2/25/21  Adaptimmune Therapeutics plc      10-K       12/31/20  112:13M                                    Toppan Merrill Bridge/FA
 8/10/20  Adaptimmune Therapeutics plc      S-3ASR      8/10/20    5:1.6M                                   Toppan Merrill/FA
Top
Filing Submission 0001104659-20-003256   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 10:10:17.2pm ET